RE: General meeting notes10 Mar 2026 08:22
With regard to offtake agreements, it was communicated that the company is not currently committing to a binding offtake arrangement. The view expressed was that delaying such agreements represents a prudent strategy given the strong current interest in rare earth supply and the anticipated growth in demand. Reference was also made to ex-China pricing trends, suggesting that rare earth prices are expected to strengthen. Consequently, the view communicated was that delaying binding offtake commitments could allow the company to secure more favourable pricing terms.
The 2027 production timeline was addressed during the meeting, with the objective stated as achieving commissioning towards the end of 2027.
On the subject of downstream processing and broader supply chain participation, there was no clear indication that the company intends to own downstream processing assets.
My interpretation of the discussion is that the strategic approach is to focus on building partnerships across the supply chain.
Specifically, this could involve working with midstream processing partners such as Solvay, eVac and ReElement, while also developing relationships with OEMs, with examples including Apple and Microsoft.
The intention would be to maximise value extraction from the underlying resource across the supply chain, particularly during periods of favourable pricing, without necessarily owning or operating the entire mine-to-magnet production pathway.
Personal interpretation of the discussion (opinion):
* The Cascade equity investment could take a few months to complete.
* The ABSA debt facility, supported by the EXIM guarantee, may follow approximately 6–9 months after the equity component is finalised.
* A binding offtake agreement could occur at any point, depending on the board’s discretion and prevailing market conditions.
* The target of commissioning by the end of 2027 appears optimistic, given the number of steps that remain in the development and financing process.